SARS-CoV-2-specific IgG detection with a rapid antibody
Clinical significance of SARS-CoV-2-specific IgG detection with a rapid antibody kit for COVID-19 patients
- Background: The longitudinal observation of the detection of antibody responses to SARS-CoV-2 using antibody kits during the clinical course of COVID-19 is not yet fully investigated.
- Objectives: To understand the significance of the detection of anti-SARS-CoV-2 antibodies, particularly IgG, using a rapid antibody kit, during the clinical course of COVID-19 patients with different severities.
- Methods: Sixty-three serum samples from 18 patients (5 asymptomatic and 13 symptomatic patients) were retrospectively examined using a commercial SARS-CoV-2 IgM/IgG antibody kit. PCR positivity of patient samples was also examined as a marker of current SARS-CoV-2 infection.
- Results: IgG antibodies were detected in all cases in this study. The IgG detection rates reached 100.0% in samples collected on day 13 or later. IgG seropositivity after an initial negative status was observed in 13 patients (3/5 asymptomatic and 10/13 symptomatic cases). Interestingly, the persistence of both PCR and IgG positivity was detected in seven cases, of which three were asymptomatic. The longest overlap duration of the PCR and IgG positivity was 17 days in asymptomatic status.
- Conclusions: SARS-CoV-2-specific IgG production can be detected in all infected individuals, using a rapid antibody kit, irrespective of clinical status. However, these findings suggest that, in some infected individuals, particularly those with asymptomatic status, the presence of virus-specific IgG antibodies does not imply prompt viral clearance.
enviroshieldproducts
 anti- LIF antibody |
|||
| FNab09804 | FN Test | 100µg | EUR 658.5 |
|
|||
|
Description: Antibody raised against LIF |
|||
 Mouse LIF ELISA Kit |
|||
| EML0014 | Abclonal | 96Tests | EUR 625.2 |
 Mouse LIF shRNA Plasmid |
|||
| 20-abx971321 | Abbexa |
|
|
|
|||
 Recombinant Mouse LIF Protein |
|||
| R01400-1 | BosterBio | 100ug/vial | EUR 352.8 |
 ELISA kit for Mouse LIF |
|||
| EK5250 | SAB | 96 tests | EUR 663.6 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Mouse LIF in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
 Mouse LIF PicoKine ELISA Kit |
|||
| EK0580 | BosterBio | 96 wells | EUR 510 |
|
Description: For quantitative detection of mouse LIF in cell culture supernates, serum and plasma (heparin, EDTA). |
|||
 (pORF)) Lif ORF Vector (Mouse) (pORF) |
|||
| ORF049145 | ABM | 1.0 ug DNA | EUR 607.2 |
|
Lif ORF Vector (Mouse) (pORF) |
|||
| ORF049146 | ABM | 1.0 ug DNA | EUR 607.2 |
 LIF, Mouse Recombinant , 1MIU/ml |
|||
| L4500-001 | GenDepot | 1ml | EUR 406.8 |
|
LIF, Mouse Recombinant , 1MIU/ml |
|||
| L4500-005 | GenDepot | 5x1ml | EUR 1431.6 |
 (OKEH04045)) LIF ELISA Kit (Mouse) (OKEH04045) |
|||
| OKEH04045 | Aviva Systems Biology | 96 Wells | EUR 652.8 |
|
Description: Description of target: LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.;Species reactivity: Mouse;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 0.039 ng/mL |
|||
 (OKBB00760)) LIF ELISA Kit (Mouse) (OKBB00760) |
|||
| OKBB00760 | Aviva Systems Biology | 96 Wells | EUR 606 |
|
Description: Description of target: Leukemia inhibitory factor, or LIF, is an interleukin 6 class cytokine that affects cell growth by inhibiting differentiation. When LIF levels drop, the cells differentiate. The LIF was mapped gene to 22q11-q12.2 by Southern analysis of a series of mouse/human somatic cell hybrids and by in situ hybridization to the chromosomes of 2 normal males and some individuals with chromosomal rearrangements. The gene maps between the Philadelphia translocation BCR1 and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF derives its name from its ability to induce the terminal differentiation of myeloid leukemic cells, thus preventing their continued growth. Other properties attributed to the cytokine include: the growth promotion and cell differentiation of different types of target cells, influence on bone metabolism, cachexia, neural development, embryogenesis and inflammation.;Species reactivity: Mouse;Application: ELISA;Assay info: ;Sensitivity: <10pg/ml |
|||
 LIF, Mouse Recombinant , 10MIU/ml |
|||
| L4501-001 | GenDepot | 1ml | EUR 1744.8 |
 Nori® Mouse LIF ELISA Kit |
|||
| GR117058 | Genorise Scientific | 96-well | EUR 461 |
 Human CellExp? LIF, mouse recombinant |
|||
| 7268-10 | Biovision | each | EUR 444 |
, mouse) Leukemia Inhibitory Factor (LIF), mouse |
|||
| PR16102 | Neuromics | 5 ug | EUR 522 |
) Lif sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3872501 | ABM | 3 x 1.0 ug | EUR 406.8 |
 LIF Antibody |
|||
| 6245-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
|||
|
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation. |
|||
|
LIF Antibody |
|||
| 6245-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
|||
|
Description: LIF Antibody: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. LIF was initially recognized by its ability to induce terminal differentiation of myeloid leukemic cells. It is a member of the IL-6 cytokine superfamily and can be highly glycosylated. LIF signaling is transduced through the LIF-R/gp130 receptor complex, leading to the phosphorylation and activation of the JAK/STAT pathway. Recent evidence shows that LIF inhibits cardiomyogenesis in embryonic stem cells via STAT3 activation. |
|||
|
LIF Antibody |
|||
| 5216-100 | Biovision | each | EUR 379.2 |
|
LIF Antibody |
|||
| 5216-30T | Biovision | each | EUR 175.2 |
 LIF antibody |
|||
| 70R-12299 | Fitzgerald | 100 ug | EUR 483.6 |
|
Description: Rabbit polyclonal LIF antibody |
|||
|
LIF antibody |
|||
| 70R-14100 | Fitzgerald | 100 ug | EUR 386.4 |
|
Description: Affinity purified Rabbit polyclonal LIF antibody |
|||
|
LIF Antibody |
|||
| 25283-100ul | SAB | 100ul | EUR 468 |
|
LIF antibody |
|||
| 70R-51295 | Fitzgerald | 100 ul | EUR 292.8 |
|
Description: Purified Polyclonal LIF antibody |
|||
|
LIF antibody |
|||
| 70R-6230 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal LIF antibody |
|||
|
LIF Antibody |
|||
| 36950-100ul | SAB | 100ul | EUR 302.4 |
|
LIF Antibody |
|||
| 1-CSB-PA012928ESR2HU | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
|
LIF Antibody |
|||
| 1-CSB-PA198481 | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:10000, IHC:1:25-1:100 |
|||
|
LIF Antibody |
|||
| 1-CSB-PA004761 | Cusabio |
|
|
|
|||
|
Description: A polyclonal antibody against LIF. Recognizes LIF from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
|||
|
LIF Antibody |
|||
| DF13730 | Affbiotech | 100ul | EUR 420 |
|
LIF Antibody |
|||
| F49998-0.08ML | NSJ Bioreagents | 0.08 ml | EUR 140.25 |
|
Description: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. |
|||
|
LIF Antibody |
|||
| F49998-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
|
Description: LIF is a pleiotropic cytokine with roles in several different systems. It is involved in the induction of hematopoietic differentiation in normal and myeloid leukemia cells, induction of neuronal cell differentiation, regulator of mesenchymal to epithelial conversion during kidney development, and may also have a role in immune tolerance at the maternal-fetal interface. |
|||
|
LIF antibody |
|||
| PAab09804 | Lifescience Market | 100 ug | EUR 463.2 |
|
LIF Antibody |
|||
| R36251-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
|
Description: Additional name(s) for this target protein: Leukemia inhibitory factor |
|||
|
LIF Antibody |
|||
| R30639 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: LIF is a pleiotropic cytokine produced at the maternal-fetal interface which has been shown to play an essential role in implantation in mice. It is produced in high amounts by the human endometrium and the trophoblast itself, and its receptors are present on cytotrophoblast cells. LIF could thus play a role in modulating HLA-G production and immune tolerance at the maternal-fetal interface. The gene maps to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2. |
|||
|
LIF Antibody |
|||
| R31467 | NSJ Bioreagents | 100 ug | EUR 356.15 |
|
Description: LIF is a pleiotropic cytokine produced at the maternal-fetal interface which has been shown to play an essential role in implantation in mice. This gene is mapped to 22q11-q12.2, between the Philadelphia translocation BCR gene and the breakpoint of the translocation in cell line GM2324 at 22q12.2. LIF is produced in high amounts by the human endometrium and the trophoblast itself, and LIF receptors are present on cytotrophoblast cells. It could, thus, play a role in modulating HLA-G production and immune tolerance at the maternal-fetal interface. |
|||
 Polyclonal Antibody (Mouse)) Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse) |
|||
| 4-PAA085Mu01 | Cloud-Clone |
|
|
|
|||
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF) |
|||
 anti-LIF |
|||
| YF-PA12952 | Abfrontier | 50 ug | EUR 435.6 |
|
Description: Mouse polyclonal to LIF |
|||
) LIF, Leukemia inhibitory factor, murine (mouse) |
|||
| RC234-18 | Bio Basic | 5ug | EUR 125.26 |
|
|||
 Protein) Mouse Leukemia Inhibitory Factor (LIF) Protein |
|||
| 20-abx067761 | Abbexa |
|
|
|
|||
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|||
| abx262959-1mg | Abbexa | 1 mg | EUR 3801.6 |
|
|||
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|||
| abx262959-3x10g | Abbexa | 3x10 µg | EUR 393.6 |
|
|||
|
Mouse Leukemia Inhibitory Factor (LIF) Protein |
|||
| abx262959-3x2g | Abbexa | 3x2 µg | EUR 276 |
|
|||
 Recombinant Mouse Leukemia Inhibitory Factor/lIF |
|||
| C690-10ug | Novoprotein | 10ug | EUR 175.2 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
|
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
|||
| C690-1mg | Novoprotein | 1mg | EUR 2739.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
|
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
|||
| C690-500ug | Novoprotein | 500ug | EUR 1935.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
|
Recombinant Mouse Leukemia Inhibitory Factor/lIF |
|||
| C690-50ug | Novoprotein | 50ug | EUR 363.6 |
|
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
|||
 (pPM-C-HA)) LIF Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV196580 | ABM | 500 ng | EUR 723.6 |
|
LIF Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV196584 | ABM | 500 ng | EUR 723.6 |
 (pPB-C-His)) LIF Protein Vector (Mouse) (pPB-C-His) |
|||
| PV196578 | ABM | 500 ng | EUR 723.6 |
 (pPB-N-His)) LIF Protein Vector (Mouse) (pPB-N-His) |
|||
| PV196579 | ABM | 500 ng | EUR 723.6 |
 (pPM-C-His)) LIF Protein Vector (Mouse) (pPM-C-His) |
|||
| PV196581 | ABM | 500 ng | EUR 723.6 |
|
LIF Protein Vector (Mouse) (pPB-C-His) |
|||
| PV196582 | ABM | 500 ng | EUR 723.6 |
|
LIF Protein Vector (Mouse) (pPB-N-His) |
|||
| PV196583 | ABM | 500 ng | EUR 723.6 |
|
LIF Protein Vector (Mouse) (pPM-C-His) |
|||
| PV196585 | ABM | 500 ng | EUR 723.6 |
 ELISA Kit) Mouse Lif(Leukemia inhibitory factor) ELISA Kit |
|||
| EM0237 | FN Test | 96T | EUR 681.12 |
|
|||
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 46.9pg/ml |
|||
 Mouse Lif/ Leukemia inhibitory factor ELISA Kit |
|||
| E1656Mo | Sunlong | 1 Kit | EUR 655.2 |
 [His]) Mouse LIF Protein (Ser 24-Phe 203) [His] |
|||
| VAng-1946Lsx-20g | Creative Biolabs | 20 µg | EUR 588 |
|
Description: Mouse LIF protein, His tag, expressed in human 293 cells. (Uniprot ID: P09056) |
|||
|
Mouse LIF Protein (Ser 24-Phe 203) [His] |
|||
| VAng-1946Lsx-50g | Creative Biolabs | 50 µg | EUR 1050 |
|
Description: Mouse LIF protein, His tag, expressed in human 293 cells. (Uniprot ID: P09056) |
|||
 Polyclonal Antibody (Mouse), PE) Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), PE |
|||
| 4-PAA085Mu01-PE | Cloud-Clone |
|
|
|
|||
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with PE. |
|||
 Polyclonal Antibody (Mouse), APC) Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), APC |
|||
| 4-PAA085Mu01-APC | Cloud-Clone |
|
|
|
|||
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with APC. |
|||
 Polyclonal Antibody (Mouse), Cy3) Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), Cy3 |
|||
| 4-PAA085Mu01-Cy3 | Cloud-Clone |
|
|
|
|||
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with Cy3. |
|||
 Polyclonal Antibody (Mouse), HRP) Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), HRP |
|||
| 4-PAA085Mu01-HRP | Cloud-Clone |
|
|
|
|||
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with HRP. |
|||
 Recombinant Mouse LIF Protein, Untagged, E.coli-1mg |
|||
| QP4235-1mg | EnQuireBio | 1mg | EUR 3189.6 |
 Recombinant Mouse LIF Protein, Untagged, E.coli-5ug |
|||
| QP4235-5ug | EnQuireBio | 5ug | EUR 163.2 |
 Polyclonal Antibody (Mouse), FITC) Leukemia Inhibitory Factor (LIF) Polyclonal Antibody (Mouse), FITC |
|||
| 4-PAA085Mu01-FITC | Cloud-Clone |
|
|
|
|||
|
Description: A Rabbit polyclonal antibody against Mouse Leukemia Inhibitory Factor (LIF). This antibody is labeled with FITC. |
|||
Rapid ‘mix and read’ assay for scalable detection of SARS-CoV-2 antibodies in patient plasma
The human beta coronavirus SARS-CoV-2, causative virus of COVID-19, has infected more than 15 million people globally and continues to spread. Widespread, population level testing to detect active and past infections is critical to curb the COVID-19 pandemic. Antibody (serological) testing is the only option for detecting past infections outside the narrow window accessible to nucleic acid-based tests. However, currently available serological assays commonly lack scalability.
Here, we describe the development of a rapid homogenous serological assay for the detection of antibodies to SARS-CoV-2 in patient plasma. We show that the fluorescence-based assay accurately detects seroconversion in COVID-19 patients from less than 1 microliter of plasma. Using a cohort of samples from COVID-19 infected or healthy individuals, we demonstrate detection with 100% sensitivity and specificity. This assay addresses an important need for a robust, low barrier to implementation, and scalable serological assay with complementary strengths to currently available serological platforms.
A cost analysis study of the implementation of fixed-dosing of monoclonal antibodies in the Netherlands Cancer Institute
Background There is a strong rationale for fixed-dosing of monoclonal antibodies in oncology. Although fixed-dosing of recently introduced monoclonal antibodies is well accepted, the rationale is also applicable for other monoclonal antibodies that already have been used for years, but are still body-size-based dosed in many hospitals.
In the Netherlands Cancer Institute, Antoni van Leeuwenhoek (NKI-AVL), fixed-dosing has been implemented now for all monoclonal antibodies and, therefore, this site offers an ideal opportunity for a cost analysis study. Objective To investigate the financial impact of switching to fixed-dosing in the NKI-AVL. Setting The NKI-AVL. Method Information on the preparations of monoclonal antibodies was collected from August 2017 to February 2020. We compared the number of vials needed during preparation for fixed-dosing and body-size -based dosing strategies.
The economic impact was calculated for 2 scenarios: scenario 1 assumed clustering of all preparations per day and scenario 2 assumed no clustering of preparations. Main outcome measure Number of saved vials and the correlating savings in health care costs. Results The implementation of fixed-dosing resulted in a substantial reduction in vials used for almost all monoclonal antibodies.
The economic savings were calculated to be €0,8 and €3,1 million per year for scenario 1 and 2, respectively. Conclusion Fixed-dosing resulted in substantial savings in health care costs.
 anti- IL-17 antibody |
|||
| FNab04224 | FN Test | 100µg | EUR 658.5 |
|
|||
|
Description: Antibody raised against IL-17 |
|||
anti- IL-17 antibody |
|||
| FNab04225 | FN Test | 100µg | EUR 606.3 |
|
|||
|
Description: Antibody raised against IL-17 |
|||
 Anti-IL-17 antibody |
|||
| PAab04224 | Lifescience Market | 100 ug | EUR 463.2 |
 Anti-IL-17 alpha antibody |
|||
| STJ93683 | St John's Laboratory | 200 µl | EUR 236.4 |
|
Description: Rabbit polyclonal to IL-17Ralpha. |
|||
 Recombinant Human IL-17 |
|||
| SJB09-03 | Amyotop | 25µg/vial | EUR 307.2 |
 CLIA Kit) Human Interleukin 17 (IL-17) CLIA Kit |
|||
| abx195860-96tests | Abbexa | 96 tests | EUR 990 |
|
|||
 Human Interleukin 17,IL-17 ELISA Kit |
|||
| 201-12-0143 | SunredBio | 96 tests | EUR 528 |
|
|||
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
|||
Human Interleukin 17,IL-17 ELISA Kit |
|||
| CN-03335H1 | ChemNorm | 96T | EUR 520.8 |
Human Interleukin 17,IL-17 ELISA Kit |
|||
| CN-03335H2 | ChemNorm | 48T | EUR 340.8 |
ELISA Kit) Human Interleukin 17(IL-17)ELISA Kit |
|||
| GA-E0081HM-48T | GenAsia Biotech | 48T | EUR 346.8 |
Human Interleukin 17(IL-17)ELISA Kit |
|||
| GA-E0081HM-96T | GenAsia Biotech | 96T | EUR 559.2 |
Human Interleukin 17(IL-17)ELISA Kit |
|||
| QY-E04323 | Qayee Biotechnology | 96T | EUR 433.2 |
Human Interleukin 17,IL-17 ELISA Kit |
|||
| YLA1538HU-48T | Shanghai YL Biotech | 48T | EUR 435 |
Human Interleukin 17,IL-17 ELISA Kit |
|||
| YLA1538HU-96T | Shanghai YL Biotech | 96T | EUR 562.5 |
 IL-17 Interleukin-17 Human Recombinant Protein |
|||
| PROTQ16552-1 | BosterBio | Regular: 25ug | EUR 380.4 |
|
Description: Interleukin-17A Human Recombinant produced in E.Coli is a homodimeric, non-glycosylated polypeptide chain containing a total of 264 amino acids (2 chains of 132 aa) and having a molecular mass of 31kDa. ;The IL-17 is purified by proprietary chromatographic techniques. |
|||
 Protein) Recombinant Human IL-17 (IL-17A) Protein |
|||
| PROTQ16552-4 | BosterBio | 25ug | EUR 380.4 |
|
Description: The originally described IL-17 protein, now known as IL-17A, is a homodimer of two 136 amino acid chains, secreted by activated T-cells that act on stromal cells to induce production of proinflammatory and hematopoietic bioactive molecules. Today, IL-17 represents a family of structurally-related cytokines that share a highly conserved C-terminal region but differ from one another in their N-terminal regions and in their distinct biological roles. The six known members of this family, IL-17A through IL-17F, are secreted as homodimers. IL-17A exhibits cross-species bioactivity between human and murine cells. Recombinant human IL-17A is a 31.3 kDa disulfide-linked homodimer of two 137 amino acid polypeptide chains. |
|||
 human IL-17, His tag |
|||
| E410A10-100 | EnoGene | 100μg | EUR 1152 |
 ELISA Kit) IL-17 (Human) ELISA Kit |
|||
| E4628-100 | Biovision | each | EUR 874.8 |
 Human IL-17 ELISA kit |
|||
| LF-EK50201 | Abfrontier | 1×96T | EUR 777.6 |
 IL-17 ELISA KIT|Human |
|||
| EF006939 | Lifescience Market | 96 Tests | EUR 826.8 |
 Antibody) Interleukin 17 (IL-17) Antibody |
|||
| abx234224-100ug | Abbexa | 100 ug | EUR 610.8 |
|
|||
Interleukin 17 (IL-17) Antibody |
|||
| abx234225-100ug | Abbexa | 100 ug | EUR 577.2 |
|
|||
 IL-17 Antibody |
|||
| 5176-100 | Biovision | each | EUR 405.6 |
IL-17 Antibody |
|||
| 4877-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
|||
|
Description: IL-17 Antibody: Interleukin 17 (IL-17) is a family of pro-inflammatory cytokines produced by activated T cells and is thought to have a major role in the initiation and perpetuation of rheumatoid arthritis. IL-17 regulates the activities of NF-κB and mitogen-activated protein kinases such as ERK and JNK. In addition, IL-17 stimulates the expression of IL-6 and cyclooxygenase-2 and enhances the production of nitric oxide. IL-17-producing T helper cells (TH-17 cells) have been the subject of much attention due to the importance of IL-17 in the pathogenesis of autoimmune inflammation. Because of its role in autoimmune diseases, it is thought that targeting the production and action of IL-17 would be beneficial therapeutically in these diseases. |
|||
IL-17 Antibody |
|||
| 4877-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
|||
|
Description: IL-17 Antibody: Interleukin 17 (IL-17) is a family of pro-inflammatory cytokines produced by activated T cells and is thought to have a major role in the initiation and perpetuation of rheumatoid arthritis. IL-17 regulates the activities of NF-κB and mitogen-activated protein kinases such as ERK and JNK. In addition, IL-17 stimulates the expression of IL-6 and cyclooxygenase-2 and enhances the production of nitric oxide. IL-17-producing T helper cells (TH-17 cells) have been the subject of much attention due to the importance of IL-17 in the pathogenesis of autoimmune inflammation. Because of its role in autoimmune diseases, it is thought that targeting the production and action of IL-17 would be beneficial therapeutically in these diseases. |
|||
IL-17 Antibody |
|||
| 4887-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
|||
|
Description: IL-17 Antibody: Interleukin 17 (IL-17) is a family of pro-inflammatory cytokines produced by activated T cells and is thought to have a major role in the initiation and perpetuation of rheumatoid arthritis. IL-17 regulates the activities of NF-κB and mitogen-activated protein kinases such as ERK and JNK. In addition, IL-17 stimulates the expression of IL-6 and cyclooxygenase-2 and enhances the production of nitric oxide. IL-17-producing T helper cells (TH-17 cells) have been the subject of much attention due to the importance of IL-17 in the pathogenesis of autoimmune inflammation. Because of its role in autoimmune diseases, it is thought that targeting the production and action of IL-17 would be beneficial therapeutically in these diseases. |
|||
IL-17 Antibody |
|||
| 4887-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
|||
|
Description: IL-17 Antibody: Interleukin 17 (IL-17) is a family of pro-inflammatory cytokines produced by activated T cells and is thought to have a major role in the initiation and perpetuation of rheumatoid arthritis. IL-17 regulates the activities of NF-κB and mitogen-activated protein kinases such as ERK and JNK. In addition, IL-17 stimulates the expression of IL-6 and cyclooxygenase-2 and enhances the production of nitric oxide. IL-17-producing T helper cells (TH-17 cells) have been the subject of much attention due to the importance of IL-17 in the pathogenesis of autoimmune inflammation. Because of its role in autoimmune diseases, it is thought that targeting the production and action of IL-17 would be beneficial therapeutically in these diseases. |
|||
IL-17 Antibody |
|||
| 24784-100ul | SAB | 100ul | EUR 468 |
IL-17 Antibody |
|||
| 24789-100ul | SAB | 100ul | EUR 468 |
IL-17 Antibody |
|||
| F42568-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 322.15 |
|
Description: The protein encoded by this gene is a proinflammatory cytokine produced by activated T cells. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. |
|||
IL-17 Antibody |
|||
| R35097-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
|
Description: Additional name(s) for this target protein: Interleukin 17A; IL17A |
|||
IL-17 Antibody |
|||
| R36188-100UG | NSJ Bioreagents | 100 ug | EUR 339.15 |
|
Description: Additional name(s) for this target protein: Interleukin 17A antibody, IL17A, CTLA8 |
|||
) CLIA kit for Human IL-17 (Interleukin 17) |
|||
| E-CL-H0104 | Elabscience Biotech | 1 plate of 96 wells | EUR 700.8 |
|
|||
|
Description: A sandwich CLIA kit for quantitative measurement of Human IL-17 (Interleukin 17) in samples from Serum, Plasma, Cell supernatant |
|||
) ELISA kit for Human IL-17 (Interleukin 17) |
|||
| E-EL-H0105 | Elabscience Biotech | 1 plate of 96 wells | EUR 452.4 |
|
|||
|
Description: A sandwich ELISA kit for quantitative measurement of Human IL-17 (Interleukin 17) in samples from Serum, Plasma, Cell supernatant |
|||
 Detection Assay Kit) Human Interleukin 17 (IL-17) Detection Assay Kit |
|||
| 6808 | Chondrex | 1 kit | EUR 580.26 |
|
Description: Human Interleukin 17 (IL-17) Detection Assay Kit |
|||
 IL-17 Interleukin-17 Human Recombinant Protein, HEK |
|||
| PROTQ16552 | BosterBio | Regular: 10ug | EUR 380.4 |
|
Description: IL-17 Human Recombinant produced in HEK cells is a glycosylated homodimer, having a molecular weight range of 30-35kDa due to glycosylation.;The IL-17 is purified by proprietary chromatographic techniques. |
|||
 IL-17 |
|||
| E5-00007 | EnoGene | 1mg | EUR 1152 |
IL-17 |
|||
| MO15110 | Neuromics | 500 ug | EUR 1092 |
IL-17 |
|||
| EF014060 | Lifescience Market | 96 Tests | EUR 826.8 |
IL-17 |
|||
| PR27113 | Neuromics | 5 ug | EUR 229.2 |
 IL-17/IL-17A |
|||
| E21-021 | EnoGene | 10ug | EUR 411.6 |
 ELISA kit for Human IL-17 |
|||
| KET6022-48T | Abbkine | 48T | EUR 242.4 |
|
|||
|
Description: Quantitative sandwich ELISA for measuring Human IL-17 in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human IL-17 |
|||
| KET6022-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 1292.4 |
|
|||
|
Description: Quantitative sandwich ELISA for measuring Human IL-17 in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
ELISA kit for Human IL-17 |
|||
| KET6022-96T | Abbkine | 96T | EUR 346.8 |
|
|||
|
Description: Quantitative sandwich ELISA for measuring Human IL-17 in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
|||
) Human IL-17 ELISA kit (4X96T) |
|||
| LF-EK50202 | Abfrontier | 4×96T | EUR 2641.2 |
 CymaxTM Human IL-17 ELISA Kit |
|||
| LF-EK0295 | Abfrontier | 1×96T | EUR 477.6 |
 Human IL-17 PicoKine ELISA Kit |
|||
| EK0430 | BosterBio | 96 wells | EUR 510 |
|
Description: For quantitative detection of human IL-17 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
|||
 IL-17 Interleukin-17 Human Recombinant Protein, His Tag |
|||
| PROTQ16552-2 | BosterBio | Regular: 10ug | EUR 380.4 |
|
Description: Interleukin-17A Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 132 amino acids fragment (24-155) having a molecular weight of 19.62kDa and fused with a 4.5kDa amino-terminal hexahistidine tag. ;The IL-17A His is purified by proprietary chromatographic techniques. |
|||
 ELISA Kit) Human Interleukin 17A (IL-17A/IL-17) ELISA Kit |
|||
| CSB-E12819h-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
|||
|
Description: Quantitativesandwich ELISA kit for measuring Human Interleukin 17A (IL-17A/IL-17) in samples from serum, urine, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human Interleukin 17A (IL-17A/IL-17) ELISA Kit |
|||
| 1-CSB-E12819h | Cusabio |
|
|
|
|||
|
Description: Quantitativesandwich ELISA kit for measuring Human Interleukin 17A (IL-17A/IL-17) in samples from serum, urine, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
 Polyclonal IL-17 Antibody |
|||
| APR06508G | Leading Biology | 0.1 mg | EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human IL-17 . This antibody is tested and proven to work in the following applications: |
|||
Polyclonal IL-17 Antibody |
|||
| APR06512G | Leading Biology | 0.1 mg | EUR 790.8 |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human IL-17 . This antibody is tested and proven to work in the following applications: |
|||
) Bovine Interleukin 17(IL-17) |
|||
| QY-E60069 | Qayee Biotechnology | 96T | EUR 511.2 |
 IL-17 Peptide |
|||
| 4877P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (NT) IL-17 peptide |
|||
IL-17 Peptide |
|||
| 4887P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (IN) IL-17 peptide |
|||
 Genorise® Anti-canine IL-17 Polyclonal Antibody |
|||
| GR105162 | Genorise Scientific | 100 ug | EUR 438 |
 Human Interleukin-17,IL-17A ELISA Kit |
|||
| ELA-E1700h | Lifescience Market | 96 Tests | EUR 988.8 |
 IL-17 receptor D antibody |
|||
| 22228-100ul | SAB | 100ul | EUR 468 |
) Recombinant Human IL-17 Receptor A/IL-17RA/CD217 (C-Fc) |
|||
| CI53-10ug | Novoprotein | 10ug | EUR 120 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Human IL-17 Receptor A/IL-17RA/CD217 (C-Fc) |
|||
| CI53-1mg | Novoprotein | 1mg | EUR 1094.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Human IL-17 Receptor A/IL-17RA/CD217 (C-Fc) |
|||
| CI53-500ug | Novoprotein | 500ug | EUR 850.8 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
Recombinant Human IL-17 Receptor A/IL-17RA/CD217 (C-Fc) |
|||
| CI53-50ug | Novoprotein | 50ug | EUR 242.4 |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
|||
 ELISA Kit) Human IL-17A(Interleukin 17 A) ELISA Kit |
|||
| EH3267 | FN Test | 96T | EUR 571.5 |
|
|||
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 18.75pg/ml |
|||
 Genorise® Biotinylated Anti-equine IL-17 Polyclonal Antibody |
|||
| GR109027 | Genorise Scientific | 50 mg | EUR 398 |
 Genorise® Biotinylated Anti-canine IL-17 Polyclonal Antibody |
|||
| GR109179 | Genorise Scientific | 50 mg | EUR 398 |
 ELISA Kit) Human Interleukin-17 A (IL-17A) ELISA Kit |
|||
| LF-EK60049 | Abfrontier | 1×96T | EUR 948 |
 Anti Human 17? HSD 8 Polyclonal Antibody |
|||
| KR099 | Sceti | each | EUR 778.8 |
|
Description: The Anti Human 17? HSD 8 Polyclonal Antibody is available in Europe and for worldwide shipping via Gentaur. |
|||
 IL-17 Recombinant Protein |
|||
| 91-616 | ProSci | 0.05 mg | EUR 588.3 |
|
Description: Interleukin-17 is a potent pro-inflammatory cytokine produced by activated memory T cells. There are at least six members of the IL-17 family in humans and in mice. As IL-17 shares properties with IL-1 and TNF-alpha, it may induce joint inflammation and bone and cartilage destruction. This cytokine is found in synovial fluids of patients with rheumatoid arthritis, and produced by rheumatoid arthritis synovium. It increases IL-6 production, induces collagen degradation and decreases collagen synthesis by synovium and cartilage and proteoglycan synthesis in cartilage. IL-17 is also able to increase bone destruction and reduce its formation. Blocking of interleukin-17 with specific inhibitors provides a protective inhibition of cartilage and bone degradation. |
|||